XML 36 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings Per Share Attributable to Common Shareholders (Tables)
3 Months Ended
Mar. 31, 2013
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earning Per Share
The following table provides the detailed calculation of Earnings per common share:
 
 
Three Months Ended
(IN MILLIONS)
 
March 31,
2013

 
April 1,
2012

EPS Numerator––Basic
 
 
 
 
Income from continuing operations
 
$
2,761

 
$
1,724

Less: Net income attributable to noncontrolling interests(a)
 
23

 
9

Income from continuing operations attributable to Pfizer Inc.
 
2,738

 
1,715

Less: Preferred stock dividends––net of tax
 

 

Income from continuing operations attributable to Pfizer Inc common shareholders
 
2,738

 
1,715

Discontinued operations––net of tax
 
4

 
79

Net income attributable to Pfizer Inc. common shareholders
 
$
2,742

 
$
1,794

EPS Numerator––Diluted
 
 

 
 

Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
2,738

 
$
1,715

Discontinued operations––net of tax
 
4

 
79

Net income attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
2,742

 
$
1,794

EPS Denominator
 
 

 
 

Weighted-average number of common shares outstanding––Basic
 
7,187

 
7,537

Common-share equivalents: stock options, stock issuable under employee compensation plans and convertible preferred stock
 
82

 
61

Weighted-average number of common shares outstanding––Diluted
 
7,269

 
7,598

Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(b)
 
97

 
223

(a) 
Our 80.2%-owned Animal Health subsidiary, Zoetis, has issued securities, under its share-based compensations programs, that enable the holders to obtain Zoetis common stock under certain circumstances and, as such, those shares are included in computing Zoetis' earnings per share information on a standalone basis. The per-share earnings of Zoetis are included in our consolidated earnings per share calculations based on our proportionate share in Zoetis' common stock and common stock equivalents.
(b) 
These common stock equivalents were outstanding for the three months ended March 31, 2013 and April 1, 2012, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.